Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 29.00
+0.10 (0.35%)
At close: Jun 16, 2026
Orion Pharma Market Cap
Orion Pharma has a market cap or net worth of 6.79 billion as of June 16, 2026. Its market cap has increased by 5.07% in one year.
Market Cap
6.79B
Enterprise Value
35.10B
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.00
Market Cap Chart
Since March 20, 2013, Orion Pharma's market cap has decreased from 14.66B to 6.79B, a decrease of -53.72%. That is a compound annual growth rate of -5.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 6.79B | 5.84% |
| Dec 30, 2025 | 6.41B | -27.70% |
| Dec 30, 2024 | 8.87B | -52.39% |
| Dec 28, 2023 | 18.63B | -3.75% |
| Dec 29, 2022 | 19.35B | -9.22% |
| Dec 30, 2021 | 21.32B | 66.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 26.03B |
| The ACME Laboratories | 17.03B |
| Asiatic Laboratories | 15.19B |
| The IBN SINA Pharmaceutical Industry | 9.80B |
| Navana Pharmaceuticals | 7.76B |
| Techno Drugs | 5.85B |
| Silco Pharmaceuticals | 2.16B |
| Indo-Bangla Pharmaceuticals | 1.84B |